Portfolio update September 2025
A weak month for the portfolio, but with three deep dives published, plenty to think about.
Indonesia's leading chocolate manufacturer at 8.8x 2026e P/E. Estimated reading time: 20 minutes
Disclaimer: Asian Century Stocks uses information sources believed to be reliable, but their accuracy cannot be guaranteed. The information contained in this publication is not intended to constitute individual investment advice and is not designed to meet your personal financial situation. The opinions expressed in such publications are those of the publisher and are subject to change without notice. You are advised to discuss your investment options with your financial advisers and to understand whether any investment is suitable for your specific needs. From time to time, I may have positions in the securities covered in the articles on this website. Full disclosure: I hold a position in Delfi when publishing this article. Note that this is a disclosure and not a recommendation to buy or sell.
Table of contents:
1. Quick recap
2. Update since my first write-up
2.1. Delfi’s post-COVID recovery
2.2. New products
2.3. Alt-data update
2.4. Insider buying
2.5. New analyst coverage
3. What will change for Delfi?
3.1. Cocoa prices
3.2. Underlying chocolate demand
3.3. Capital expenditures
3.4. Ozempic
3.5. Succession planning
3.6. Potential buy-out?
4. Valuation multiples
5. Conclusion
My initial report on Indonesian chocolate producer Delfi (DELFI SP - US$416 million) was published in April 2021. You can find the full report here:
My 2021 Q&A with Delfi’s investor relations team can be found here.
In my original report on Delfi, I noted the following:
Since my initial report on Delfi in April 2021, the share price rallied to a peak of SG$1.44 as the company recovered from COVID-19. More recently, the share price has dropped to around SG$0.90, which I think is related to the headwind of sharply rising cocoa prices.
Delfi’s performance over the past few years has been excellent. Revenues are now 22% above the pre-COVID level, even in US Dollar terms, Delfi’s reporting currency. You can tell from the following chart that operating profit (red line) has also rebounded strongly since 2021. Delfi has been growing nicely.
If you’re wondering why revenues dropped in 2011, Delfi divested its cocoa ingredient business to Switzerland’s Barry Callebaut in that year. But adjusting for this revenue drop, Delfi has performed satisfactorily, especially since 2018.
Here is Delfi’s income statement, showing how the business has grown over the past few years:
As you can tell, revenues have grown nicely, most recently at +12.7% year-on-year. Delfi’s strong revenue growth was mostly due to the opening of Indonesia’s economy after heavy social distancing restrictions during COVID-19. Delfi’s premium brands, including its Van Houten-branded chocolate bars, are doing well.
But the gross profit margin fell further, from 30.5% in 2022 to 28.5% in 2023:
The gross profit margin dropped in 2019 due to the adoption of a new accounting standard where trade promotions are now counted as part of net sales. If you adjust the margin for the shift in the account of trade promotions, the 2018 level would have been 29%.
Delfi explained the recent margin compression by stating that it had to spend more on marketing to address heightened competition and to push new product launches:
“These declines can be attributed to higher marketing expenses, partly to address heightened competition in Indonesia, and to fund more brand building initiatives.”
In 2018, Delfi acquired a regional license for the Van Houten brand for US$13 million, allowing it to market chocolates in certain key markets in Asia and Oceania with the Van Houten brand name. Van Houten is an old European chocolate brand now owned by the Barry Callebaut group in Switzerland. Delfi has been pushing this brand, as long as its other premium chocolate varieties, through its distribution channels, partly through greater trade promotions.
But also note that Delfi’s inventory balance almost doubled in 2022, with company-wide inventory days going from 83 to 126. Since cost of goods sold is calculated by deducting end-of-year inventory, it’s possible that an overvaluation of inventory in December 2022 caused Delfi’s gross profit margins to go up in 2022 and then down 2023.
The 2023 results also mask incremental weakness in Delfi’s margins towards the end of the year. In the second half of 2022, revenue growth decelerated to just +9.0% year-on-year, while Delfi’s net profit dropped -14.1% year-on-year:
The gross profit margin weakened further to 27.3% in the second half of 2023, and again, this seems to be due to competition and investments in new brands.
The big elephant in the room is cocoa prices. They’ve gone up significantly since late 2022. Delfi is downplaying the issue but it’s clear to me that cocoa must become a challenge to the company at some point, if it hasn’t already.
Delfi’s product innovation continues to impress me. They’re heading in the right direction, in my view.
For example, in 2021, Delfi launched the Van Houten Dark Milk variants with more cocoa and less sugar. While people in the region typically do not like dark chocolate, its popularity is growing. The new varieties include dark milk chocolate, dark milk almond, dark milk hazelnuts, 52% cocoa almonds and dark milk fruit & nut. I’ve tried these and will continue to buy them.
On the SilverQueen side, Delfi launched two new flavors in 2021: Very Berry and Matcha Green Tea. These are yoghurt chocolate products with cashew nuts inside. These two new flavors were also launched under the Goya brand name in the Philippines.
Goya also launched two other flavors: Black Cookie Crunch and Winter Chill:
For Delfi’s M&M style chocolate product ChaCha, Delfi launched several collaborations with Mickey Mouse, Frozen, Toy Story and Tsum Tsum to drive sales:
In 2022, Delfi created an entirely new brand called 7+, a cereal brand catering to consumers searching for healthier snacking options:
In 2023, Delfi’s JV with Orion launched the O’Rice snacking product and has expressed a positive view on it. These are rice crackers, which remind me of what Want Want is selling in China.
And finally, in late 2023, Delfi launched a vegan version of Van Houten chocolate with no dairy, eggs or honey. The flavors on offer include coconut almond, salted caramel and finally, almond & berries:
To be honest, I think that very few of these products will become successes. Delfi’s growth is primarily driven by SilverQueen, which has become a hit product. And the Van Houten brand certainly has potential. But in any case, it’s great to see that Delfi continues to innovate.
The number of Google search queries for the key SilverQueen brand rose nicely throughout 2022 and 2023. The spike during Valentine’s Day in February 2024 was much lower than in prior years, and I’m not sure why.
There’s been talk about competitors spending more on advertising and promotion, but as far as I can tell Mayora Indah is mostly focused on wafers and cookies with Mayora Indah’s Beng Beng chocolate product not visibly taking market share.
In mid-2022, I noticed that Delfi advertised for a larger number of job positions at its Bandung factory than before, including project engineers and maintenance personnel. At the time, I speculated that a recovery in production volumes might be taking place.
There’s also been a shake-up in the board and among senior executives:
Some investors expressed concern about this high management turnover. But I think this reflects that the Chuang family runs Delfi, and they have high expectations of their staff. Since I believe in John Chuang, I’m not particularly worried about this turnover.
In January 2023, the controlling shareholder “Berlian” - owned by the Chuang brothers - had acquired an additional 2.4 million shares, increasing their position to 52.4%. At the time, the share price was hovering around the SG$0.80 level, suggesting a decent entry price. You can find the related SGX disclosure here.
In 2023, we saw several brokers initiating coverage of Delfi:
I don’t pay much attention to sell-side analysts, but I find it interesting that there’s been a pick-up in interest in the stock. The weak analyst coverage of Delfi has been a key differentiating factor between itself and Jakarta-listed competitor Mayora Indah. Perhaps the sell-side is finally starting to pay attention to the company.
The big elephant in the room for Delfi is the sudden spike in cocoa prices from late 2022 onwards, rising from US$2,400/ton to now over US$7,000. I sense speculative euphoria, with industry analysts now predicting prices going above US$10,000.
Deep reports for serious, Asia-focused investors.
By subscribing, I agree to Asian Century Stocks' Terms and Conditions, and acknowledge its Privacy Policy.